Donor pretreatment with IFN-gamma enhances MHC class Ii antigen expression and accelerates graft rejection by modified recipients
Ijzermans, J.N.; Bouwman, E.; Jeekel, J.; Marquet, R.L.
Transplantation Proceedings 22(4): 1941-1942
1990
ISSN/ISBN: 0041-1345 PMID: 2117821 Document Number: 356452
Document emailed within 1 workday
Related Documents
Kalovidouris, A.E. 1992: The role of cytokines in polymyositis: interferon-gamma induces class Ii and enhances class i major histocompatibility complex antigen expression on cultured human muscle cells Journal of Laboratory and Clinical Medicine 120(2): 244-251Blazar, B.R.; Taylor, P.A.; Fitzsimmons, W.E.; Vallera, D.A. 1994: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation Journal of Immunology 153(4): 1836-1846
Yasunaga, C.; Cramer, D.V.; Chapman, F.A.; Wang, H.K.; Barnett, M.; Wu, G.D.; Makowka, L. 1993: Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium Transplantation Proceedings 25(3 Suppl. 2): 65-66
Sumimoto, R.; Kamada, N. 1991: Immunosuppressive effect of soluble class i antigen and its complexes with monoclonal antibody on advanced heart graft rejection in rats Transplantation Proceedings 23(1 Part 1): 86-88
Glas, R.; Waldenström, M.; Höglund, P.; Klein, G.; Kärre, K.; Ljunggren, H.G. 1995: Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft Cancer Research 55(9): 1911-1916
Schmid, T.; Oberhuber, G.; Korozsi, G.; Klima, G.; Margreiter, R. 1990: Major histocompatibility complex class Ii antigen expression on enterocytes during rejection of small-bowel allografts Transplantation Proceedings 22(6): 2480
Pegrum, G.D.; Williams, G.; Markwick, J.; Barnes, R.M. 1976: Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction Postgraduate Medical Journal 52(5 Suppl): 47-50
Goto, M.; Yamaguchi, Y.; Matsuno, K.; Takata, N.; Makino, Y.; Kikuchi, N.; Hamaguchi, H.; Hisama, N.; Otsuka, Y.; Mori, K. 1993: Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: the distribution of donor class I-positive cells in the recipient Transplantation Proceedings 25(2): 1893-1895
Kloover, J.S.; Soots, A.P.; Krogerus, L.A.; Kauppinen, H.O.; Loginov, R.J.; Holma, K.L.; Bruggeman, C.A.; Ahonen, P.J.; Lautenschlager, I.T. 2000: Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft Transplantation 69(12): 2641-2647
Hedfors, E.; Lindahl, G. 1990: Variation of MHC class i and Ii antigen expression in relation to lymphocytic infiltrates and interferon-gamma positive cells Journal of Rheumatology 17(6): 743-750
Goguel, A.F.; Le Borgne, F.; Baude, B.; Canavate, M.L.; Tlouzeau, S.; Derhy, M.L.; Lespinats, G. 1990: MHC class i antigen expression and alterations induced by rIFN gamma in tumor hybrid cell immunogenicity In Vivo 4(3): 185-190
Green, W.R.; Phillips, J.D. 1986: Differential induction of H-2K vs H-2D class i major histocompatibility complex antigen expression by murine recombinant interferon-gamma Journal of Immunology 137(3): 814-818
Donaldson, P.T.; Thomson, L.J.; Heads, A.; Underhill, J.A.; Vaughan, R.W.; Rolando, N.; Williams, R. 1995: IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry Transplantation 60(9): 1016-1023
Toma, H.; Tanabe, K.; Oba, S.; Horita, S.; Takahashi, K.; Teraoka, S.; Ota, K. 1987: Expression of class Ii antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity Transplantation Proceedings 19(5): 3719-3720
Parikh, Y.; Toledo-Pereyra, L.H.; Finkelstein, I.; Bandlien, K.; Castellanos, J.; Mittal, V. 1987: Prolonged pancreas transplant survival following graft donor pretreatment with cyclosporine a or concanavalin a Transplantation Proceedings 19(5): 4336-4339
Takemura, Y.; Koide, Y.; Kawabata, M.; Kitajima, S.; Ohba, C.; Suzuki, H.; Sekiguchi, S. 1989: Synergistic enhancement of class i major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination Experimental Hematology 17(7): 795-799
Azuma, T.; Sato, S.; Kitagawa, S.; Hori, S.; Kokudo, S.; Hamaoka, T.; Fujiwara, H. 1989: Tolerance induction of allo-class i H-2 antigen-reactive Lyt-2+ helper T cells and prolonged survival of the corresponding class i H-2-disparate skin graft Journal of Immunology 143(1): 1-8
Boström, L.; Ringdén, O.; Forsgren, M. 1992: Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease Transplantation Proceedings 24(1): 376-377
Süsal, C.; Terness, P.; Opelz, G. 1987: Suppression of graft-versus-host reaction in rats by pretreatment of donor cells with a non-cytotoxic immunosuppressive serum Transplantation Proceedings 19(1 Pt 1): 572-575
Chen, S.; Ascher, N.L.; Bach, F.H.; Simmons, R.L. 1979: Graft rejection in donor-recipient pairs with differing of H-2 loci Surgical Forum 30: 274-276